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Whi3 is an RNA-binding protein associated with the endo-
plasmic reticulum (ER) that binds the CLN3mRNA and plays a
key role in the efficient retention of cyclin Cln3 at the ER. In the
present work, we have identified newWhi3-associated mRNAs
by a genomic approach. A large and significant number of these
Whi3 targets encode for membrane and exocytic proteins
involved in processes such as transport and cell wall biogenesis.
Consistent with the genomic data, we have observed that cell
wall integrity is compromised inWhi3-deficient cells and found
strong genetic interactions betweenWHI3 and the cell integrity
pathway. Whi3-associated mRNAs are enriched in clusters of
the tetranucleotide GCAU, and mutation of the GCAU clusters
in the CLN3 mRNA caused a reduction in its association to
Whi3, suggesting that these sequences may act as cis-determi-
nants for binding. Our data suggest thatWhi3 is involved in the
regulation and/or localization of a large subset of mRNAs func-
tionally related to the ER and, since it is important for different
molecular processes such as cytoplasmic retention or exocytic
traffic of proteins, we propose thatWhi3 is a general modulator
of protein fate in budding yeast.
RNA-binding proteins are involved in posttranslational reg-
ulation affecting diverse aspects such as stability, translation,
and transport ofmRNAs (1). Different data from genomic array
analysis revealed that RNA-binding proteins associate with dis-
crete subpolulations of the total mRNAs in the cell (2, 3). Par-
ticular mRNA-binding proteins would regulate mRNAs from
different subpopulations of functionally related genes (4),
which have been referred to as posttranscriptional operons (5).
The transport and local translation of mRNAs are key
steps in the regulation of protein localization (6, 7). The
majority of mRNAs encoding secreted and membrane-
bound proteins are translated in polysomes associated with
the ER5 membrane (8). Some of these proteins show a signal
peptide sequence in the N terminus that is rapidly recog-
nized by the signal recognition particle (SRP) after transla-
tion initiation. The SRP binds to a receptor localized in the
ERmembrane facilitating the association of the polysomes to
the ER and facilitating the internalization of the nascent pro-
tein across the ER membrane by a translation-coupled
mechanism. However, by using subcellular fractionation and
genomic analysis, a large number of ER-associated mRNAs
have been identified that encode proteins without a signal
peptide tag (9). Since SRP-deficient cells are viable and still
have sufficient levels of protein synthesis on the ER (10),
specific determinants in the mRNA-containing ribonucleo-
particles have been hypothesized that would recognize pro-
tein receptors at the ER surface (11). As an example of an
SRP-independent mechanism, the RNA-binding proteins
She2/3 recruit a significant set of mRNAs to the ER as a key
step for efficient transport of the associated mRNAs to the
bud (12–14).
Whi3 is an ER-associated protein that contains a C-termi-
nal RNA recognition motif (RRM), being functionally
involved in cell size and cell cycle regulation (15). Whi3
binds to the mRNA of CLN3 (16), the most upstream activa-
tor of cell cycle entry in Saccharomyces cerevisiae (17, 18),
with no obvious effects on mRNA or protein levels. Cln3 is
mostly ER-associated in early G1 cells and accumulates in the
nucleus in late G1 (19, 20). Whi3 is important for efficient
retention of Cln3 at the ER in early G1 and prevents unsched-
uled nuclear accumulation of Cln3. On the other hand,Whi3
interacts with the Cdc28 kinase, and we have proposed that
Whi3 confines translation of Cln3 in the ER to efficiently
retain newly formed Cln3-Cdc28 complexes (19). Whi4,
which displays some similarities in the RRM and Cter
regions (15), seems to play a partially redundant role toWhi3
in cell size control (15, 21). In addition to cell size regulation,
Whi3 is essential for filamentous growth, but the effectors
and targets of Whi3 in this process are unknown (22). The
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role of Whi3 in cell filamentation is dependent on the pres-
ence of the RRM motif and is largely independent of Cln3
function (16, 19), suggesting the existence of additional
Whi3 targets.
Polysome partitioning between cytosol and ER serves to
direct proteins to different compartments in eukaryotic
cells, and the existence of different pathways for RNA traffic
to the ER is widely accepted (8, 11). Whi3 is an RNA-binding
protein associated to the ER, which makes it an interesting
candidate for mRNA partitioning. In this work, we have used
a genomic approach to identify new mRNA targets of Whi3,
and we have obtained a list of more than 300 candidates that
includes the mRNA of CLN3. The analysis of the data
revealed that a significant number of Whi3-associated
mRNAs encode for membrane and exocytic proteins, sug-
gesting that Whi3 is involved in the regulation of ER-associ-
ated mRNAs. Since Whi3 is involved in ER-mediated reten-
tion and traffic of proteins, we hypothesize that Whi3 would
localize mRNA translation at the ER and act as a general
modulator of protein fate in budding yeast.
EXPERIMENTAL PROCEDURES
Yeast Strains, Plasmids, and Growth Conditions—Strains
used in pull-down experiments are SC0000 (MATa ade2 arg4
leu2-3,112 ura3-52 trp1-289) derivatives and were obtained
from Euroscarf. Strains used in functional analysis derive from
our parental strain CML128 (MATa leu2-3,112 ura3-52 trp1-1
his4 canI-r) (23). Yeast cell cultures and genetic manipulations
were carried out as described (24–26), andDNAmanipulations
were performedby standardmethods (27). Yeast cellswere rou-
tinely grown in rich medium (YPD; 1% yeast extract, 2% pep-
tone, and 2% dextrose) at 30 °C unless stated otherwise. Where
needed, sorbitol was added to a final concentration of 0.8 M.
CalcofluorWhite (Sigma) was used at a final concentration of 8
g/ml. Congo Red (Sigma) was added to a final concentration
of 10g/ml. For selection of plasmid-bornemarkers, yeast cells
were grown inminimal medium (SD; 0.67% yeast nitrogen base
and 2% dextrose), and supplements were added as required.
Plasmid YEP352-SLT2-3HA (H. Torres) harbors the corre-
sponding open reading frame under its own promoter into a
2-based multicopy vector. Plasmid pCM194 is a YCplac33
derivative that contains three-hemagglutinin (3HA)-tagged
CLN3 open reading frame under the control of its own pro-
moter (23). The CLN3mGCAU allele was obtained by in vitro
synthesis (Genecust-Biobasic) and cloned by in vivo recombi-
nation in pCM194. In previous work, we have demonstrated
that the 3-untranslated region, containing two GCAU tet-
ranucleotides, is not relevant for the Whi3 regulation (16, 19).
Details of strain and plasmid constructions are available upon
request.
Affinity Purification Procedure—The method for extract
preparation was adapted from Rigaut et al. (28) as described
(16). Briefly, extracts were prepared from 1 liter of yeast cells
grown to log phase (A600  1). Cells harboring centromeric
plasmids were grown initially in selective minimal medium,
diluted in YPDmedium, and grownmore than 8 h. Cell growth
was halted by adding ice into the culture, and all subsequent
stepswere performed at 4 °C. Buffer A (10mMK-Hepes, pH 7.9,
10 mM KCl, 1.5 mM MgCl2, 0.5 mM dithiothreitol, and protein
inhibitors) was added to frozen pellets, and cells were broken by
passing them twice through a French press. The extract was
adjusted to a final concentration of 200 mM KCl and 1% Triton
and then centrifuged at 4500  g for 2 min. Samples for input
RNA and protein were taken from the supernatant at this step.
The remaining extractwas added to a columncontaining 100l
of Sepharose-IgG beads (Amersham Biosciences), allowing the
liquid to drain by gravity flow. Beads were quickly washed twice
with IPP150 (10 mM Tris-Cl, pH 8, 150 mMNaCl, 0.1% Triton),
allowing the buffer to drain by gravity flow. Finally, washed IgG
beads were eluted directly with 1 ml of TRIzol (Invitrogen).
Input and IP RNAs were purified by using the PureLink total
RNA purification system kit (Invitrogen).
Microarrays Analysis—cDNA was synthesized from 10–15
g of input RNA or 0.7–1 g of IP RNA. An indirect labeling
method with amino-allyl-dUTP (Ambion) was used as
described previously with slight modifications (29). We used
priming from both an anchored oligo(dT)20 primer and ran-
dom hexamers (Invitrogen). As we had multiple independ-
ent IPs for each strain, we labeled some IPs with Cy5 and
their corresponding inputs with Cy3 and vice versa. The
Cy3- and Cy5-labeled cDNAs (IP versus input) were mixed
and hybridized to spotted DNA microarrays, which will be
described in detail elsewhere.6 Briefly, our arrays contained
PCR-amplified DNA fragments targeting 5800 S. cerevi-
siae genes (including 56 small nucleolar RNAs and small
nuclear RNAs). Also, arrays contained probes targeting the
3-untranslated region of some 500 genes in addition to the
open reading frame-targeting probe. Most cell cycle-regu-
lated genes described by Spellman et al. (30) were spotted
four times at different locations in the array to assess for spot
consistency. Microarrays were scanned with an Axon Gene-
pix 4100A scanner (MDS Analytical Technologies), and data
were generated with the Genepix Pro 5 software. We per-
formed a visual quality control to flag abnormally looking
spots. Then, spots with low signal-to-noise ratios (3) in
both channels, and those with fewer than 60 pixels were
removed. Arrays were normalized by an intensity-dependent
method (print-tip loess) implemented in the GEPAS package
on the web (31). Median pixel intensities and background
subtraction were used, and the software produced normal-
ized log2 ratios (IP/input) of the median pixel intensity for
each spot. For duplicated spots in the array, inconsistent
spots as defined by having a value departing more than 0.5
from their median were removed, and the median of consist-
ent duplicated spots was taken as representative value for
that gene. We selected as candidate targets those genes that
were in the 90 percentile or higher in at least four of the six
Whi3-IPs. This amounted to 340 probes targeting 337 genes.
Of these, we removed 11 genes that passed this selection
criterion in the mock IPs.
Miscellaneous—We have used a signal amplificationmethod
to detect endogenous levels of Cln3-3HA by immunofluores-
cence (16). Slides were sequentially incubated with rat anti-HA
6 F. Ferrezuelo, M. Aldea, and B. Futcher, manuscript in preparation.
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(clone 3F10, Roche Applied Science) and goat anti-rat and rab-
bit anti-goat antibodies labeled with Alexa Fluor 555 (Molecu-
lar Probes). To analyze nuclear accumulation of Cln3, Image J
software was used to set a threshold to outline the cytoplasm of
most cells in the immunofluorescence image. The threshold
was increased 2-fold, and outlined regions were scored as pos-
itive nuclei by visual comparisonwith a stacked 4,6-diamidino-
2-phenylindole image.
Yeast cells growing exponentially in YPD at A600 0.5 were
used to obtain cell volume distributions with a Z2 Coulter
counter (16). Cells harboring centromeric plasmidswere grown
initially in selective minimal medium, diluted in YPDmedium,
and grown overnight.
Protein extracts and Western blot analysis with mouse
anti-HA (clone 12CA5) and anti-phospho-P44/P42 (New Eng-
land Biolabs) antibodies were performed as described previ-
ously (23, 32). TAP-tagged proteins were detected with a per-
oxidase-labeled rabbit anti-peroxidase antibody-soluble
complex (Sigma) (28). Protein concentration in supernatants
was determined by a Micro DC protein assay (Bio-Rad), and
equivalent amounts of total protein extracts were run on SDS-
polyacrylamide gels. Chemiluminescent detection was per-
formed using a Lumi-Imager system (Roche Applied Science).
RESULTS
Identification of mRNAs Associated with Whi3—To identify
mRNAs associated with Whi3, we performed pull-down
experiments with a Whi3-TAP-tagged strain (16). This pro-
cedure yielded sufficient RNA for labeling without amplifi-
cation by reverse transcription-PCR (3, 33). Whi3-associ-
ated mRNAs and total RNA were used to produce labeled
cDNAs and then mixed and hybridized to DNAmicroarrays.
The same procedure was performed with untagged cells as
control (mock). We performed six independent experiments
with the Whi3-TAP strain and five with the untagged strain
(supplemental Table S1). As expected for a specific capture
in pull-down experiments, the distribution of mRNAs bound
to Whi3 showed an asymmetric pattern (Fig. 1). Approxi-
mately 3.7% of mRNAs were situated beyond two positive
standard deviations compared with only a 0.95% of mRNAs
beyond two negative standard deviations. On the contrary,
the distribution of the mock isolates was symmetrical, indi-
cating irrelevant enrichment of mRNAs. In a previous work,
we had described the specific interaction of theCLN3mRNA
with the Whi3 protein (16). In the arrays, which contained
four CLN3 spots distributed at different locations, the
mRNA of CLN3 was clearly enriched in all the Whi3-TAP
samples with an average log2 ratio of 1.98, whereas in the
mock samples, the average log2 ratio was 0.03 (Fig. 1).
Moreover, this enrichment was repetitive and consistent in
all the CLN3 spots among the different experiments, giving
strong support to the validity of our results. To define a
group of targets specific to Whi3, we applied a ranking
approach by selecting those genes that were in the 90 per-
centile or higher in at least four of the six Whi3-IPs. Follow-
ing the same criterion, we only found 11 sequences of small
nucleolar RNAs that were also consistently enriched in the
mock sample. After removal of these mock sequences, we
FIGURE1.Pull-downdistributions.Distributionsof log2ratiosobtainedbyaver-
agingall independentmicroarrayhybridizationexperiments for each strain,wild
type (SC0000), and the TAP-tagged versions of Whi3 (SC3304), Whi4 (SC3411),
Dpm1 (SC1622), and Sfb3 (SC2482) are shown. Values are plotted scaled to the
population standard deviations. The distribution of selected Whi3 targets is
shown in red, and the position of CLN3 is marked by an arrow.
mRNA Targets of the Cell Development RegulatorWhi3
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obtained a list with 326 enriched mRNAs in our Whi3-TAP
samples (Fig. 2A; supplemental Table S1). Consistently,
CLN3 was located among the top 20 candidates. The consis-
tency of the list was highly reproducible independently of the
application of other statistical methods for selection and
cutoff.7
We also applied the same pull-down analysis to determine
the target mRNAs for Whi4, which shares some structural and
functional similarities with Whi3 (15). In three independent
experiments using the Whi4-TAP strain, we obtained lower
signals in the microarray, perhaps due to the lower amounts of
Whi4 in the pull-down samples when compared with Whi3
(data not shown). Nonetheless, the genes enriched in Whi3
experiments were also slightly enriched in Whi4 pull-down
samples (Figs. 1 and 2A). In agreement with this result, Whi3
andWhi4 show partial functional redundancy as deduced from
their phenotypical analysis (Refs. 15 and 21 and see below).
Many mRNAs selected by their association to Whi3 encode
membrane- and ER-associated proteins (see below). Given that
Whi3 is localized in ER fractions (20), the enrichment in the
pull-down sample could be caused
by the presence of contaminant ER
structures bound to Whi3. To
exclude this possibility, we used two
strains harboring the ER-associated
proteins Dpm1 and Sfb3 tagged
with the TAP epitope as controls.
We carried out four pull downswith
theDpm1-TAP strain and three pull
downs with the Sfb3-TAP strain
(supplemental Table S1). The pro-
tein Dpm1 contains a transmem-
brane domain that is anchored to
the ER. Dpm1 was insoluble in our
non-denaturing extracts and unde-
tectable in the supernatant of cell
extracts after centrifugation (see
“Experimental Procedures”) (data
not shown), indicating the absence
of contaminating ER membranes in
the extracts. Microarray analysis of
Dpm1-TAP pull-downs produced
very similar results to those
obtained with the untagged strain
and, accordingly,Whi3 targets were
not found significantly enriched
(Figs. 1 and 2A). Sfb3 was soluble in
non-denaturing extracts, perhaps
due to the fact that it associates to
the cytoplasmic face of the ER and
was detected in the pull-down sam-
ples (data not shown). Despite that,
the distribution of mRNAs in the
pull downs with this strain was also
similar to the untagged strain as
shown by cluster analysis (Fig. 2B),
being that theWhi3 targets are not enriched either (Figs. 1 and
2A). Additionally, we compared our list of genes with available
data for mRNAs bound to She proteins (14). These proteins are
associated to the ER and are required to transport several
mRNAs to the bud. The majority of Whi3 targets were not
found among those bound by She proteins (data not shown),
which further supports the specificity of our pull-down analysis
with the Whi3-TAP strain.
Whi3 Significantly Binds mRNAs Encoding Membrane and
Exocytic Proteins—To gain insight into the function ofWhi3 as
an RNA-binding protein, we classified the Whi3-associated
transcripts by the subcellular localization of their coded prod-
ucts according to theMIPS yeast genome data base (34) and the
Saccharomyces Genome Data base (SGD) (35). Out of the 326
Whi3-associated transcripts, the localization data were avail-
able for 306 candidates, which were categorized in five distinct
cell compartments similarly as described previously by Kumar
et al. (36) (Fig. 3A). Remarkably, the exocytosis network and
plasma membrane compartments were substantially enriched
in comparison with the entire yeast genome. The exocytosis
network is a broad compartment that includes proteins local-
ized in the ER and along the secretory pathway but also a large7 N. Colomina, F. Ferrezuelo, H.Wang,M. Aldea, and E. Garı´, unpublisheddata.
FIGURE 2. Identification of Whi3-associated mRNAs. A, TreeView generated heat map showing the top 50
candidate targets forWhi3. Genes are in rows; independent replicate IPs are in columns. Yellowdenotes enrich-
ment in the IP relative to the input RNA. Log2 ratio values are plotted. B, correlation analysis of all the arrays
performed in this study. The software Cluster 3.0 (51) was used to cluster arrays using an uncentered Pearson
correlation similaritymetric and average linkage. Othermetrics gave similar results. Java TreeViewwas used to
generate the tree.
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number of secreted proteins finally localized in the cell periph-
ery. In accordance with this, the analysis of the data in the Gene
Ontology (GO) data base showed that the Whi3 targets were
significantly enriched in transcripts encoding proteins local-
ized in the ER, cell wall, and plasma membrane (Fig. 3B). Con-
comitantly, our data showed that a relevant part of the proteins
encoded by Whi3-associated transcripts contain a transmem-
brane domain (Fig. 3C), among them the 84.6% of plasmamem-
brane targets and the 56% of exocytic network targets. A 21.5%
of the proteins encoded byWhi3 targets show a putative signal
peptide tag (34, 35). This percentage rises to 50% for the targets
grouped in the exocytosis network, indicating that a significant
fraction of Whi3 targets encodes for proteins likely translo-
cated to the ER lumen. Then, the overall analysis of the data
suggests that Whi3 significantly binds transcripts encoding
membrane and exocytic proteins. Assuming that the majority
of these transcripts are translated in ER-associated polysomes,
we propose that Whi3 binds specifically to ER-associated
mRNAs. This is in agreement with our previous result showing
the association of Whi3 to the ER fraction (20).
We also used the Gene Ontology annotation for process and
function to analyze the list of Whi3 targets, which indicated
that the encoded proteins participate in a broad spectrum of
cell processes (supplemental Table S1). The most abundant
group of Whi3-associated mRNAs encodes for proteins
involved in transport (Fig. 3D). This group includes 52
mRNAs encoding classical membrane transporters and per-
meases and 18 transcripts involved in vesicle-mediated
transport. Additionally, other cell
processes related to the cell
periphery such as response to
chemical stimulus (10.4%) and cell
wall biogenesis (4.9%) are broadly
represented among the Whi3 tar-
gets. This is in accordance with the
presence of an elevated number of
membrane and exocytic proteins
encoded by the Whi3 targets.
A number of Whi3 targets were
also related to cell cycle progression.
In particular, 27 (8.3%) mRNAs
identified in Whi3 pull downs
encode for proteins involved in cell
cycle regulation, being highly sig-
nificant the presence of regulators
of the cyclin-dependent kinases
(CDKs) when compared with the
whole genome (p  2.47  105)
(supplemental Table S1). Besides
Cln3, other cyclins such as Cln2,
Clb6, andClb2were also enriched in
Whi3 pull downs. On the other
hand, 10 transcriptional factors
such as Yox1 or Fkh2 that regulate
different phases of the cell cycle
were also identified. Furthermore,
in agreement with the fact that
Whi3 uses N-terminal se-
quences to recruit Cdc28 (19), 14 mRNAs enriched in Whi3
pull downs encode for putative Cdc28 substrates. Thus, Whi3
associates to mRNAs that code for proteins functionally
involved in diverse roles such as transport, signaling, andmain-
tenance of cell integrity and cell cycle regulation.
Whi3 Is Required for Maintenance of Cell Integrity—Profi-
cient exocytic traffic and membrane transport are required to
maintain cell wall integrity (37). Among the Whi3-transcripts,
we have identified 17 mRNAs encoding cell wall proteins
involved in enzymatic and structural functions. Consequently,
Whi3may be important tomaintain cell integrity at least under
some specific conditions of growth. Remarkably, the Whi3
homologue in Schizosaccharomyces pombe, the RNA-binding
protein Scw1, has been involved in the maintenance of cell wall
structure (38, 39). To test whether Whi3 is important in the
control of cell integrity, we challenged Whi3-deficient cells
with cell-wall inhibitory drugs such as Congo Red and Cal-
cofluor White, which cause deleterious effects on growth (37).
As shown in Fig. 4A, whi3 cells were more sensitive to Congo
Red and Calcofluor White when compared with wild type.
Moreover, this phenotypewas dependent on the ability ofWhi3
to bind mRNAs since deletion of the RRM in Whi3 produced
the same growth defect. Although the whi4 mutant was as
resistant as the wild type, the double whi3whi4mutant was
muchmore sensitive to Congo Red andCalcofluorWhite when
compared with the whi3 single mutant, reinforcing the idea
that Whi4 may play somewhat redundant roles with Whi3.
Interestingly, both single whi3 and double whi3whi4
FIGURE 3. Characterization ofWhi3 targets. A, classification of proteins encoded for by theWhi3-associated
mRNAs based on subcellular localization information gathered from MIPS (34) and SGD (35) data bases. The
percentage of each compartment is indicated inside the chart. The percentages of the yeast proteome were
obtained from Kumar et al. (36). The significance in the enrichment (p value) of the exocytosis network was
obtained from the Funspec data base (52) B, genes in theWhi3 data set were classified by cellular component
terms (GO component) gathered from SGD data base (see supplemental Table S1). C, analysis of the predicted
transmembrane domains in the Whi3 data set by the Simple Modular Architecture Research Tool (SMART)
domain data base (52, 53) (see supplemental Table S1, funspec data). D, Whi3 targets encode for proteins
involved in transport. Genes in the Whi3 data set were classified by biological function terms (GO function)
gathered from the SGD data base (see supplemental Table S1). B, C, andD, the comparative enrichment in the
various categories between the Whi3 data set (gray columns) and the entire yeast genome (black columns) is
depicted together with the significance values (p values).
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mutants exhibited a growth delay at 37 °C thatwas recovered by
the addition of 0.8 M sorbitol (Fig. 4B), an unambiguous symp-
tom of alterations in the protective cell cover. To confirm the
existence of anomalies in the cell wall of Whi3-deficient cells,
we evaluated phospho-Slt2 levels in the whi3 mutant. Phos-
phorylation of mitogen-activated protein (MAP) kinase Slt2 is
induced through the cell integrity pathway in response to a
broad spectrum of perturbations in the cell wall (32, 37). As
expected, whi3 cells showed an increased level of phospho-
Slt2 when compared with wild-type cells (Fig. 4C). To further
evaluate the importance ofWhi3 in cell wall integrity, we com-
bined the whi3 and slt2 mutations. This double mutant
showed a synthetic lethal phenotype at 30 °C, which was res-
cued in the presence of 0.8 M sorbitol (Fig. 4B). The overall data
suggest that the absence of Whi3 interferes with normal cell
wall development and requires an active integrity pathway for
survival.
FIGURE 4.Whi3-deficient cells show cell wall perturbations. A, evaluation
of growth sensitivity to Congo Red (CR) and Calcofluor White (CFW) drugs of
wild-type (CML128), whi3 (CML217), whi4 (CML219), whi3whi4
(CYC285), andwhi3RRM (CYC159) cells 3 days after plating a series of 5-fold
diluted spots in rich medium. B, analysis of growth capacities at different
temperatures and effects of 0.8 M sorbitol (Sorb) inwild-type (CML128),whi3
(CML217), whi4 (CML219), whi3whi4 (CYC285), slt2 (CML399), and
whi3slt2 (CYC287) cells streaked in richmedium.C,Westernblot analysis of
Slt2 phosphorylation in wild-type (CML128) and whi3 (CML217) cells har-
boring the Yep352-Slt2-3HAplasmid. Cell cultureswere exponentially grown
in minimal medium at 25 °C. Western blot analysis was performed to detect
activated (P-Slt2) and total (Slt2-3HA) amounts of Slt2. P-Kss1, activated Kss1;
P-Fus3; activated Fus3.
FIGURE 5. Whi3-associated mRNAs are enriched in clusters of the GCAU
tetranucleotide. A, to quantify the enrichment in GCAU clusters, for each
GCAU sequence in the mRNA, the distance to a third consecutive hit was
measured. Graphs show the frequency of these distances in base pairs (which
contain four consecutive GCAU hits) among theWhi3 transcripts when com-
pared with the same number of transcripts frommock pull down (Ctr IP) and
the total genome. B, same as in A for the CGUA tetranucleotide sequence.
C, the graph shows median and confidence limits for the median for each
distribution plotted in A.
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The GCAU Tetranucleotide Is a cis-Acting Determinant in
the Whi3 Targets—The consensus structure of the RRM is
composed by a four-stranded antiparallel -sheet domain that
is able to directly interact with a maximum of four nucleotides
in single-stranded nucleic acids (40). Remarkably, a three-hy-
brid screen using Whi3 as RNA-binding bait yielded a large
number of small RNA sequences with one ormore copies of the
GCAU tetranucleotide (41, 42).8 Strikingly, the CLN3 mRNA
contains two regions with five GCAU sequences each, the first
within a fragment of 150 nucleotides at the 5-untranslated
region and the secondwithin 300 nucleotides at the 3 region of
the open reading frame (19) (see Fig. 6A). We therefore carried
out a comparative study of the presence and distribution of the
GCAU sequences among the list of Whi3-associated tran-
scripts, the mock isolates, and the whole genome. Our analysis
revealed that theWhi3-associatedmRNAs showed a significant
enrichment in clusters formed by fourGCAU sequences (Fig. 5,
A and C). Although to a lesser extent, Whi3 targets were also
enriched in clusters with less than four GCAU tetranucleotides
(data not shown). The same analysis using an unrelated tet-
ranucleotide produced negative results, demonstrating the
specificity of the GCAU enrichment (Fig. 5B). To establish the
importance of these in silico data, we obtained by in vitro syn-
thesis a CLN3mGCAU allele carrying mutations in the 14 GCAT
sites in the CLN3 gene (Fig. 6A).
Mutations within the open reading
frame were conservative regarding
codon meaning to preserve protein
sequence. To analyze the efficiency
of the CLN3mGCAU mRNA as Whi3
target, we introduced 3HA-tagged
CLN3mGCAU andwild-type alleles in
a cln3 strain expressing a Whi3-
TAP fusion and performed pull-
down assays. To quantify relative
binding efficiencies of mutant and
wild-type mRNAs, CLN3 log ratios
were made relative to the average
log ratio of the top 100 mRNAs in
the Whi3 target list. As shown in
Fig. 6B, enrichment of the
CLN3mGCAU mRNA in Whi3 pull
downs was greatly diminished when
compared with the wild-type
mRNA, demonstrating the impor-
tance of the GCAU sequences in the
interactionwithWhi3.CLN3mGCAU
and wild-type mRNAs produced
very similar levels of Cln3 protein
(Fig. 6E). However, most cells
expressing the CLN3mGCAU mRNA
showed a distinctive nuclear accu-
mulation of Cln3 when compared
with cells carrying the wild-type
mRNA (Fig. 6, C and D). More
important, cells harboring the
CLN3mGCAU allele presented a reduction in cell volume similar
to Whi3-deficient cells (Fig. 6F). Thus, the CLN3mGCAU allele
recapitulates the main defects of the whi3 deletion regarding
cell cycle control in G1 and demonstrates the relevance of the
GCAU tetranucleotide as a cis-acting determinant for Whi3
binding.
DISCUSSION
Here we have identified new mRNA targets associated to
the RNA-binding protein Whi3. Analysis of Whi3 targets
revealed a significant enrichment of transcripts encoding
membrane and exocytic proteins, being that many of these
proteins are involved in cell processes such as transport and
cell wall biogenesis. In accordance with this, we have
observed that Whi3-deficient cells exhibit cell wall anoma-
lies and found strong genetic interactions with elements of
the cell integrity pathway. It is important to note that all cell
wall proteins encoded for byWhi3 targets show a signal pep-
tide tag and therefore would be transported to the cell wall
through the exocytic pathway. Previously, Whi3 has also
been involved in the exocytic pathway. The whi3 mutant
shows a reduced fitness in combination with a deletion of
PEP3, a gene encoding a subunit of class C vacuolar protein
sorting complex (43). Class C vacuolar protein sorting com-
plex regulates vesicle docking and fusion at the endosome
and vacuole, and therefore, it is important in protein sorting.8 D. J. SenGupta, S. Fields, and M. Wickens, personal communication.
FIGURE6.Mutationof theGCAUclusters in theCLN3mRNAreduces the interactionwithWhi3.A, diagram
representing the distribution of the 14 GCAU sequences (dashes) in the CLN3 mRNA that were mutated to
obtain the CLN3mGCAU allele.UTR, untranslated region;ORF, open reading frame. B, a cln3Whi3-TAP (CYC124)
strain transformedwith plasmids expressingwild-type (pCLN3) andmutant (pCLN3mGCAU)mRNAswas used for
microarray analysis ofWhi3-TAPpull downs.CLN3 ratiosweremade relative to the tophundred targets ofWhi3
obtained from experiments shown in Fig. 1. Two independent experiments for the wild-type chromosomal
CLN3 (Chr CLN3) are also shown. The values are obtained by averaging the four CLN3 spots on each array. Error
bars represent confidence limits of the mean. C, cln3 (CML211) cells expressing 3HA-tagged wild-type
(pCLN3) andmutant (pCLN3mGCAU) constructs on centromeric vectors were grown exponentially and analyzed
by immunofluorescence with an anti-HA antibody. Nuclei were detected by 4,6-diamidino-2-phenylindole
staining. Bar, 5m. D, the percentage of cells (n 300) with Cln3-3HA nuclear/cytoplasmic ratios higher than
2; confidence limits (  0.01) are plotted. E, protein extracts of cells corresponding to C were analyzed by
Western blotwith an anti-HA antibody. The asterisk indicates an unspecific band. F, cell volumedistributions of
cells corresponding to C. Wild-type (CML128) and whi3 mutant (CML217) cells growing under the same
conditions were used as internal controls.
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Overall, a strong correlation between the functional and
structural characteristics of certain Whi3 targets and the
phenotypes of Whi3-deficient cells exists. Whi3 could regu-
late stability and/or translation efficiency of their mRNA
targets. However, by microarray analysis, we have observed
that the levels of the vast majority of Whi3-associated
mRNAs were unchanged in Whi3-deficient cells (data not
shown). On the other hand, Whi3 has no obvious effects on
the levels of proteins encoded for by some mRNA targets
(Ref. 16 and data not shown), suggesting that Whi3 is not a
universal regulator of mRNA stability or translation. Instead,
we propose that Whi3 would play a role in the regulation of
their mRNA targets by localizing their translation at the
cytosolic face of the ER and/or contributing to an efficient
translocation across the ER of those encoded proteins des-
tined to the exocytic pathway. Recent findings predict the
existence of SRP-independent mechanisms to recruit
mRNAs to the cytoplasmic surface of the ER and translocate
the nascent protein into the ER lumen (8, 11). However, the
presence of a significant number ofWhi3 targets harboring a
signal peptide tag suggests the possibility that Whi3 per-
forms its function coordinated with SRP elements.
The stronger phenotype of the whi3 mutant is a com-
plete inability to grow as filaments (22). Considering our
present data, two different possibilities could explain this
defect. On the one hand, filamentation needs active exocytic
traffic and cell wall remodeling to maintain apical growth,
both of which would requireWhi3 to direct mRNA targets to
the ER as the start point of the exocytic pathway. On the
other hand, we cannot exclude the involvement of Whi3 in
ER-coupled transport of mRNAs to the daughter cell as a key
requirement for polarized growth. Similarly to She proteins,
which transport to the bud mRNAs coding for essential ele-
ments involved in apical growth such as the GTPase Cdc42
(12), Whi3 binds some mRNAs coding for proteins that reg-
ulate apical growth and cell filamentation such as cyclin Cln2
and transcription factor Tec1. Recruitment of these targets
by Whi3 could be important to drive them to the daughter
cell and efficiently maintain cell filamentation. Intriguingly,
among theWhi3 targets, we also found the transcript coding
for another RNA-binding protein, Mpt5 (supplemental
Table S1). This protein also binds the TEC1 mRNA and
modulates its translation (44). Conceivably, both Mpt5 and
Whi3 could coordinately regulate Tec1 function. Combina-
torial action of different RNA-binding proteins has been
proposed to be important to control mRNA translation and
stability (5).
Among the Whi3 targets, we have identified a considerable
number of mRNAs encoding transcription factors that are not
obviously related to ER functions. ER retention is important for
regulation of transcription factor Spt23 (45). This protein
remains anchored at the cytoplasmic face of the ER, and it is
released by a chaperone-dependent mechanism under induc-
ing conditions.One of the identifiedWhi3 targetmRNAs codes
for Aft1, a transcription factor that shows differential subcellu-
lar localization depending on iron availability (46). Heme is
involved in proper Aft1 activation. It is subject to turnover at
the ER byHmx1, allowing cells to use heme as a nutritional iron
source. Thus,Whi3 could localize synthesis of Aft1 for efficient
regulation by ER-originated signals.
In addition to CLN3, we show that Whi3 binds to mRNAs
encoding other CDK regulators including B-type cyclins,
kinase Swe1, and phosphatase Mih1. The regulation of CDK
activity is associated with the ER compartment in different
phases of the cell cycle. We have shown that the Cdc28-Cln3
complex is retained at the ER until late G1, where Ssa1,2-
Ydj1 chaperones release the complex and allow its nuclear
accumulation to trigger cell cycle entry (20). In mammals,
cyclin A is transiently maintained in the cytoplasm by reten-
tion at the ER cytoplasmic surface, and this retention is
essential for cells to enter S phase adequately (47). Also,
cyclin B2 appears to associate primarily with the Golgi appa-
ratus, whereas cyclin B1 co-localizes with microtubules (48),
where they may play important roles for ER and Golgi frag-
mentation during mitosis. The inhibition of the Clb-Cdk1
activity by Wee1 and Myt1 kinases is essential for the reas-
sembly of ER and Golgi during telophase and exit frommito-
sis (49). Thus, Whi3 may play a role in localizing translation
of the different CDK regulators on the ER to optimize func-
tional interactions among them or with their targets.
It has been demonstrated that mRNA-binding proteins
recognize specific cis-acting determinants within their tar-
gets, characterizing these common sequences a discrete sub-
population of messenger RNAs coordinately regulated (4,
50). The analysis of Whi3 targets also revealed the presence
of a cis-acting determinant for Whi3 binding. First, clusters
with four GCAU tetranucleotides were significantly
enriched among the Whi3 targets. Second, mutation of the
FIGURE 7. Whi3 as a determinant of protein fate. The diagram shows a
speculative model summarizing data obtained. Whi3 would bind ER-associ-
ated ribonucleoparticles containing specific mRNA targets enriched in GCAU
clusters. For some of them, including CLN3, Whi3 would be necessary for an
efficient retention at the ER of the encoded products. Alternatively, Whi3-
mediated recruitment of many other mRNAs would localize their translation
at the cytosolic face of the ER and/or contribute to an efficient translocation
across the ER of those encoded proteins destined to the exocytic pathway.
mRNA Targets of the Cell Development RegulatorWhi3
OCTOBER 17, 2008•VOLUME 283•NUMBER 42 JOURNAL OF BIOLOGICAL CHEMISTRY 28677
 at U
N
IV
ERSITA
T D
E LLEID
A
 on February 13, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
14 GCAU sites in the mRNA of CLN3 caused a clear reduc-
tion in its interaction with Whi3. Nonetheless, removal of
the GCAU sequences did not totally abolish the ability of
Whi3 to bind the CLN3 mRNA. This is not surprising as
protein-RNA interactions frequently depend on different
structural and/or sequence cis-determinants (50). Consider-
ing that a GCAU tetranucleotide can be bound by a single
RRM domain, the enrichment in GCAU clusters suggests
that Whi3 would form multimeric complexes on target
mRNAs. Whi3 binds both its own and the WHI4 mRNA
(supplemental Table S1), which could contribute to produce
local accumulations of these RNA-binding proteins and
form multimeric complexes.
Fig. 7 depicts a speculative model representing the cellular
roles ofWhi3. The cytoplasmic surface of the ER is an essential
compartment for protein sorting. Although recruitment of
mRNAs to the ER should be a key first step, little is known about
the determinants that anchor ribonucleoparticles to the ER sur-
face. Indeed, Whi3 may itself be a determinant for ribonucleo-
particle recruitment to the ER surface. In addition,Whi3 could
be an adaptor for other regulators of its target-mRNA encoded
proteins. For instance, we have found thatWhi3 is associated to
Ssa1,2 chaperones (19), which in turn are involved in protein
translocation across the ER membrane (8, 11) and in ER reten-
tion/release of proteins (20, 45). Additional work will be
required to uncover the precise molecular mechanisms by
which Whi3 exerts local regulatory functions on such a pleth-
ora of target mRNAs.
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